Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
Purpose: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder associated with cognitive deficits. The NF1 cognitive phenotype is generally considered to be highly variable, possibly due to the observed T2-weighted hyperintensities, loss of heterozygosity, NF1-specific genetic modifiers, or allelic imbalance. Methods: We investigated cognitive variability and assessed the contribution of genetic factors by performing a retrospective cohort study and a monozygotic twin case series. We included data of 497 children with genetically confirmed NF1 and an IQ assessment, including 12 monozygotic twin and 17 sibling sets. Results: Individuals carrying an NF1 chromosomal microdeletion showed significant lower full-scale IQ (FSIQ) scores than individuals carrying intragenic pathogenic NF1 variants. For the intragenic subgroup, the variability in cognitive ability and the correlation of IQ between monozygotic NF1 twin pairs or between NF1 siblings is similar to the general population. Conclusions: The variance and heritability of IQ in individuals with NF1 are similar to that of the general population, and hence mostly driven by genetic background differences. The only factor that significantly attenuates IQ in NF1 individuals is the NF1 chromosomal microdeletion genotype. Implications for clinical management are that individuals with intragenic NF1 variants that score <1.5–2 SD below the mean of the NF1 population should be screened for additional causes of cognitive disability.
|Keywords||genotype–phenotype association, intelligence quotient, neurofibromatosis type 1, phenotypic variability, twin study|
|Persistent URL||dx.doi.org/10.1038/s41436-020-0752-2, hdl.handle.net/1765/124697|
|Journal||Genetics in Medicine|
Ottenhoff, M.J, Rietman, A.B, Mous, S.E, Plasschaert, E, Gawehns, D. (Daniela), Brems, H, … Elgersma, Y. (2020). Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genetics in Medicine. doi:10.1038/s41436-020-0752-2